Story Summary: In addition, VisEn has launched a new near infrared label, VivoTag 800(r) to add an additional wavelength channel to its current line of VivoTag fluorochromes which are used to label specific ligands of interest in a wide variety of in vivo and in vitro imaging applications. VisEn also offers its specialized in vivo agent labeling platforms, including its proprietary VivoTag(r) fluorescence labeling dyes for custom agent development, and its NanoSpark(r) labeling nanoparticles, all designed and optimized specifically for superior biocompatibility, brightness, stability and performance in in vivo imaging. With a focus on translational research and results, all of VisEns technologies are designed to generate translational data linking pre-clinical research into clinical medicine. About VisEn Medical Inc. VisEns in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomography (FMT(TM)) Imaging Systems, provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEns FMT systems and agents are used by leading research institutions and pharmaceutical companies worldwide in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. visenmedical. com….Read the Full Story

Related posts:

1. VisEn Launches New Cat B 680 FAST(TM) Fluorescence Molecular Imaging Agent
2. VisEn Launches New Annexin-Vivo 750 Fluorescence Molecular Imaging Agent
3. VisEn Launches ReninSense680 Fast Molecular Imaging Agent to Enable In Vivo Imaging Readouts of Key Biomarkers in Hypertension and Renal Function
4. VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent
5. Microscope Capable Of Live Imaging At Double The Resolution Of Fluorescence Microscopy Developed